NCT05166096View on ClinicalTrials.gov

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

May 11, 2022

Study Completion Date

May 11, 2022

Conditions
Healthy
Interventions
DRUG

Rho-11

Subjects will be administered 325 mg aspirin by rapid IV push

DRUG

aspirin 325mg

Subjects will be administered 325 mg aspirin orally

Trial Locations (1)

78744

PPD Early Development, Austin

All Listed Sponsors
lead

Rhoshan Pharmaceuticals Inc

INDUSTRY

NCT05166096 - Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects | Biotech Hunter | Biotech Hunter